Gene: IFT80
Official Full Name: intraflagellar transport 80provided by HGNC
Gene Summary: The protein encoded by this gene is part of the intraflagellar transport complex B and is necessary for the function of motile and sensory cilia. Defects in this gene are a cause of asphyxiating thoracic dystrophy 2 (ATD2). Three transcript variants encoding two different isoforms have been found for this gene.[provided by RefSeq, Jun 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20474 | IFT80 Knockout cell line (HeLa) | Human | IFT80 | 1:3~1:6 | Negative | Online Inquiry |
KO20475 | IFT80 Knockout cell line (HCT 116) | Human | IFT80 | 1:2~1:4 | Negative | Online Inquiry |
KO20476 | IFT80 Knockout cell line (HEK293) | Human | IFT80 | 1:3~1:6 | Negative | Online Inquiry |
KO20477 | IFT80 Knockout cell line (A549) | Human | IFT80 | 1:3~1:4 | Negative | Online Inquiry |
IFT80 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to lack the expression of the IFT80 gene, which plays a pivotal role in cilia formation and function. This product serves as a critical tool for researchers studying the diverse biological processes associated with cilia, including cell signaling, cell cycle regulation, and developmental biology. By providing a controlled model system, these knockout cell lines enable the detailed investigation of how disruption in IFT80 functions can lead to various ciliopathies, which are diseases stemming from dysfunctional cilia.
These cell lines operate through the complete knockout of the IFT80 gene, which means they do not produce the IFT80 protein. The absence of this protein facilitates the examination of cilia biogenesis, movement, and its downstream effects on cellular function. Researchers can employ various biochemical and molecular techniques to study the consequences of this deletion, providing valuable insights into the underlying mechanisms of related diseases.
The scientific importance of IFT80 Gene Knockout Cell Lines extends to numerous applications in both research and clinical settings. Their utilization is crucial in understanding genetic causes of ciliopathies such as Bardet-Biedl syndrome and Meckel syndrome. By enabling researchers to elucidate the cellular pathways affected by IFT80 loss, these cell lines propel forward the development of potential therapeutic strategies and interventions.
Compared to alternative models, IFT80 Gene Knockout Cell Lines offer unique advantages. The precision of gene knockout technology ensures that researchers achieve reliable and reproducible results, making them superior to standard wild-type cell lines or those engineered with transient interference methods. Additionally, the dedicated focus on IFT80 allows for deep, specific insights that might be obscured in broader genetic approaches.
For researchers and clinicians involved in the study of ciliopathies or general cilia biology, the IFT80 Gene Knockout Cell Lines are invaluable tools that streamline the investigation of ciliary function and related pathophysiology. By choosing our product, you are leveraging state-of-the-art genetic modifications to enrich your research with precise, actionable insights.
Our company specializes in producing high-quality biological products that cater to cutting-edge research demands, ensuring that our clients have access to the most reliable tools available in the market.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.